Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Construction Advancing at Alternabis Farms

VICTORIA, Aug. 10, 2018 /CNW/ - Alternabis Farms Ltd. ("Alternabis" or the "Company") is pleased to announce construction is advancing at their new state-of-the-art cannabis production facility on Vancouver Island, British Columbia.

Alternabis (CNW Group/Alternabis)

The family-owned and operated company applied to become a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in 2014. The facility is located on a 100-acre farm that is agriculturally zoned and approved for cannabis cultivation.

"Alternabis is a passionate family business with the goal of producing premium and innovative cannabis at an affordable price," said Max Walker, Director of Marketing & Sales.

The 16,000 sq. ft. high-tech and sustainable two-floor facility will house a vast underground area and an upper-level greenhouse. This facility will position Alternabis as a new player in the Canadian cannabis market and allow the company to collect, research and breed cultivars from around the world.

"By building a two floor facility we maximize production space while minimizing our ecological footprint. We plan to use renewable energy as much as possible to run our facility. We have made our commitment to the environment an integral part of our strategy," said Bryan Walker, Director of Cultivation.

The company plans to differentiate itself from competitors by focusing on a patient base that desires exceptional cultivars and growing methods. This requires continuous R&D in order to provide medical patients with the best cannabis available.

"Patients are turning towards specialized cannabis to fulfill their needs," said Patrick Walker, Director of Operations. "Alternabis will produce this high-quality cannabis and make it affordable, accessible and sustainable."

With the new regulations allowing outdoor cannabis production, Alternabis has started to develop the 100-acre farm to produce outdoor cannabis that will be processed in a large extraction facility located on the property.

The property is located in the Cowichan region which is Canada's only Maritime Mediterranean climatic zone resulting in the warmest mean year-round temperature anywhere in Canada.

The indoor facility is expected to be operational by the end of 2018 and the company anticipates a license to cultivate at the beginning of 2019.

About Alternabis

Alternabis is a family-owned and operated business committed to helping medical patients with innovative cannabis products. Their focus on unique cultivars and cannabinoids will sprout some of the highest quality cannabis in the emerging Canadian market.

SOURCE Alternabis

These press releases may also interest you

at 07:00
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection in patients with wet age-related macular...

at 07:00
NEVADA CITY, Calif., Aug. 17, 2018 /PRNewswire-PRWeb/ -- Best Sanitizers, Inc. celebrates August as Hand Hygiene Awareness Month. CDC (Center for Disease Control and Prevention) estimates that each year roughly 1 in 6 Americans (or 48 million people)...

at 07:00
CINCINNATI, August 17, 2018 /PRNewswire-PRWeb/ -- RVers looking to enjoy the freedom of the open road before they reach the age of Medicare eligibility face the dilemma of where to obtain affordable health insurance so they can travel with peace of...

at 07:00
Symbility Solutions Inc. ("Symbility") , a global software company focused on modernizing the insurance industry, confirmed that it will release its second quarter financial results for the three months ended June 30, 2018, before the market opens on...

at 07:00
Further to its press release of June 20, 2018, Aurora Cannabis Inc. ("Aurora" or the "Company") today announced, in connection with the spin-out of its subsidiary Australis Capital Inc. ("Australis"), Australis has received a receipt for its final...

at 07:00
ITUS Corporation today announced that CEO, Dr. Amit Kumar, will be presenting at the Next Generation Dx Summit in Washington, D.C., being held on August 20th-24th.  Dr. Kumar's presentation, "Liquid Biopsy based on Flow Cytometry and Artificial...

News published on 10 august 2018 at 18:06 and distributed by: